Fox Chase Cancer Center Hosts American Cancer Society, Pennsylvania Division Meeting
PHILADELPHIA (May 16, 2001) -- Fox Chase Cancer Center recently hosted a meeting of the American Cancer Society (ACS), Pennsylvania Division Board of Directors. During the day-long meeting, ACS board members visited the laboratories of Fox Chase researchers who are ACS grant recipients.
Garry Pincock, C.E.O., ACS PA division, Sam Bressi, ACS PA Division Board Member, and Barry Bittman, M.D., ACS PA Division Board Member met with Fox Chase researcher Dr. Beatrice Mintz to discuss her work on the development of a treatment for melanoma. Mintz has received a $338,000 grant from the ACS.
Fox Chase Cancer Center, one of the nation's first comprehensive cancer centers designated by the National Cancer Institute in 1974, conducts basic and clinical research; programs of prevention, detection and treatment of cancer; and community outreach. For more information about Fox Chase activities, visit the Center's web site at www.fccc.edu.
Fox Chase Cancer Center, part of the Temple University Health System, is one of the leading cancer research and treatment centers in the United States. Founded in 1904 in Philadelphia as one of the nation’s first cancer hospitals, Fox Chase was also among the first institutions to be designated a National Cancer Institute Comprehensive Cancer Center in 1974. Fox Chase researchers have won the highest awards in their fields, including two Nobel Prizes. Fox Chase physicians are also routinely recognized in national rankings, and the Center’s nursing program has received the Magnet recognition for excellence four consecutive times. Today, Fox Chase conducts a broad array of nationally competitive basic, translational, and clinical research, with special programs in cancer prevention, detection, survivorship, and community outreach. For more information, call 1-888-FOX CHASE or (1-888-369-2427).
Media inquiries only, please contact Jeremy Moore at 215-728-2700.